However, we found that knockdown of DNMT1, but not DNMT3a and DNMT3b, resulted in restoration of FOXO3a expression, indicating that the downregulation of FOXO3a is associated with DNMT1-mediated hypermethylation of its promoter in breast cancer. Here, FOXO3 is linked to breast carcinoma.